Rejuvenation Biotechnology: How Can the PhDs Help the MDs & the MBAs?
Time: 2:35 pm
day: Day One
- Discover how one by one, anti-aging damage repair therapies are moving into (expensive) clinical trials
- Most clinical trials fail: Discuss how the rejuvenation biotechnology sector will be no different
- Why do investors often oversimplify and lose nerve? Could this badly delay availability of powerful therapies?
- Examine why researchers have huge influence over general-audience sentiment and why they must have the courage to use it